Organon (OGN) Exchange Rate Effect (2020 - 2026)
Organon (OGN) posted Exchange Rate Effect of -$3.0 million for Q2 2026, up 90.32% on a QoQ basis from -$31.0 million in Q1 2026, and down 103.23% year-over-year from $93.0 million in Q2 2025.
Analysis
Organon (OGN) Exchange Rate Effect (2020 - 2026) Analysis & Trends
Organon has reported Exchange Rate Effect for 7 years, with the latest figure at -$3.0 million in Q2 2026.
- On a quarterly basis, Exchange Rate Effect fell 103.23% year-over-year to -$3.0 million in Q2 2026; TTM through Jun 2026 was -$21.0 million, a 119.44% decrease from a year earlier, with the FY2025 full-year figure at $150.0 million, up 297.37% from the prior year.
- Exchange Rate Effect was -$3.0 million for Q2 2026 at Organon, up from -$31.0 million in the prior quarter.
- The five-year high for Exchange Rate Effect was $93.0 million in Q2 2025, with the low at -$100.0 million in Q4 2024.
- Average Exchange Rate Effect over 5 years is $1.2 million, with a median of -$3.0 million recorded in 2026.
- The sharpest annual moves came in 2022 and 2024: Exchange Rate Effect jumped 4050.0% in 2022, then slumped 1050.0% in 2024.
- Over 5 years, Exchange Rate Effect stood at $83.0 million in 2022, then plunged by 51.81% to $40.0 million in 2023, then plunged by 350.0% to -$100.0 million in 2024, then jumped by 113.0% to $13.0 million in 2025, then sank by 123.08% to -$3.0 million in 2026.
- The last three Exchange Rate Effect figures came in at -$3.0 million (Q2 2026), -$31.0 million (Q1 2026), and $13.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 5.00 Mn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | -7.00 Mn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | -37.00 Mn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | -18.00 Mn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | -4.00 Mn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 11.62 Mn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | -84,000.00 |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | - |
| 10 | Organon | 3.58 Bn | 2.45 Bn | 847.00 Mn | -3.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.00 Mn |
| Mar 31, 2026 | -31.00 Mn |
| Dec 31, 2025 | 13.00 Mn |
| Jun 30, 2025 | 93.00 Mn |
| Mar 31, 2025 | 44.00 Mn |
| Dec 31, 2024 | -100.00 Mn |
| Sep 30, 2024 | 71.00 Mn |
| Jun 30, 2024 | -23.00 Mn |
| Mar 31, 2024 | -24.00 Mn |
| Dec 31, 2023 | 40.00 Mn |
| Sep 30, 2023 | -40.00 Mn |
| Jun 30, 2023 | -2.00 Mn |
| Mar 31, 2023 | 19.00 Mn |
| Dec 31, 2022 | 83.00 Mn |
| Sep 30, 2022 | -73.00 Mn |
| Jun 30, 2022 | -34.00 Mn |
| Mar 31, 2022 | -12.00 Mn |
| Dec 31, 2021 | 2.00 Mn |
| Sep 30, 2021 | -11.00 Mn |
| Jun 30, 2021 | 45.00 Mn |